Q1 2024 Holdings
Filed 2024-05-15 | 49 holdings | $500.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Robinhood Mkts Inc(HOOD) | COM CL A | 770700102 | $54.0M | 4,237,409 | 10.8% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $49.8M | 2,924,842 | 10.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $44.8M | 3,004,199 | 8.9% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $41.7M | 2,461,350 | 8.3% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $32.0M | 1,447,401 | 6.4% |
| Blue OWL Capital Corporation(OBDC) | COM | 69121K104 | $31.5M | 2,045,070 | 6.3% |
| Klaviyo Inc(KVYO) | COM SER A | 49845K101 | $30.5M | 1,198,270 | 6.1% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $30.3M | 3,994,468 | 6.1% |
| Acelyrin Inc | COM | 00445A100 | $19.1M | 2,826,028 | 3.8% |
| Evercommerce Inc(EVCM) | COM | 29977X105 | $15.5M | 1,641,929 | 3.1% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $14.7M | 3,122,499 | 2.9% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $12.5M | 268,238 | 2.5% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $11.4M | 172,633 | 2.3% |
| Inozyme Pharma Inc | COM | 45790W108 | $9.7M | 1,270,027 | 1.9% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $9.7M | 155,260 | 1.9% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $9.1M | 1,673,877 | 1.8% |
| Toast Inc(TOST) | CL A | 888787108 | $8.0M | 322,578 | 1.6% |
| E2open Parent Holdings Inc(ETWOGBP) | COM CL A | 29788T103 | $7.3M | 1,650,943 | 1.5% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $7.0M | 541,080 | 1.4% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $5.6M | 2,829,712 | 1.1% |
| Ikena Oncology Inc | COM | 45175G108 | $5.5M | 3,891,118 | 1.1% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $5.0M | 100,000 | 1.0% |
| Dell Technologies Inc(DELL) | SHS | 24703L202 | $4.7M | 41,245 | 0.9% |
| Omega Therapeutics Inc | COMMON STOCK | 68217N105 | $3.9M | 1,055,882 | 0.8% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $3.7M | 875,000 | 0.7% |
| Direxion SHS ETF TR(LABDUSD) | DAILY S&P BIOTEC | 25460G716 | $3.6M | 490,000 | 0.7% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $3.6M | 13,319 | 0.7% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $3.5M | 695,000 | 0.7% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $3.3M | 733,568 | 0.7% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $3.2M | 100,000 | 0.6% |
| Engene Holdings Inc(ENGNW) | *W EXP 10/31/202 | 29286M113 | $2.7M | 511,177 | 0.5% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $2.6M | 864,822 | 0.5% |
| Starwood Property Trust(BRZE) | SHS | 10576N102 | $2.4M | 116,153 | 0.5% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $1.8M | 340,855 | 0.4% |
| Snowflake Inc(SNOW) | SHS | 833445109 | $1.3M | 7,819 | 0.3% |
| Gitlab, Inc(GTLB) | COM | 37637K108 | $1.2M | 20,706 | 0.2% |
| Blend Labs Inc(BLND) | CL A | 09352U108 | $1.2M | 361,587 | 0.2% |
| Gohealth Inc(GOCO) | COM CL A | 38046W204 | $875.1K | 83,264 | 0.2% |
| Desktop Metal Inc | COM CL A | 25058X105 | $660.0K | 750,000 | 0.1% |
| Rallybio Corp | COM | 75120L100 | $647.9K | 350,240 | 0.1% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $439.8K | 25,000 | 0.1% |
| Precision Biosciences Inc(DTIL) | COM NEW | 74019P207 | $274.2K | 20,220 | 0.1% |
| Fathom Digital MFG Corp | CL A COM | 31189Y103 | $230.5K | 50,000 | 0.0% |
| Geron Corporation(UBER) | COM | 90353T100 | $78.9K | 23,918 | 0.0% |
| Plum Acquisition Corp III | *W EXP 03/31/202 | G63290103 | $0 | 666,666 | 0.0% |